Advertisement
NIKI vs TVRD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NIKI is a Buy and TVRD is a Hold.
NIKI's RSI Indicator stoops into oversold zone
The RSI Oscillator for NIKI moved into overbought territory on November 10, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for NIKI just turned positive on October 27, 2026. Looking at past instances where NIKI's MACD turned positive, the stock continued to rise in 37 of 45 cases over the following month. The odds of a continued upward trend are 82%.
Following a +15.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where NIKI advanced for three days, in 157 of 195 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
NIKI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NIKI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for NIKI entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.056) is normal, around the industry mean (3.498). P/E Ratio (-0.832) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. NIKI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NIKI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
TVRD in upward trend: price rose above 50-day moving average on November 09, 2026
TVRD moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 35 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on TVRD as a result. In 66 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for TVRD just turned positive on October 15, 2026. Looking at past instances where TVRD's MACD turned positive, the stock continued to rise in 27 of 38 cases over the following month. The odds of a continued upward trend are 71%.
Following a +64.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where TVRD advanced for three days, in 185 of 227 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TVRD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
TVRD broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TVRD entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.524) is normal, around the industry mean (3.498). P/E Ratio (-0.334) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. TVRD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TVRD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
NIKI | TVRD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 2 | 46 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 39 Fair valued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 99 | |
PRICE GROWTH RATING 1..100 | 97 | 61 | |
P/E GROWTH RATING 1..100 | 6 | 7 | |
SEASONALITY SCORE 1..100 | 38 | 47 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NIKI's Valuation (39) in the Pharmaceuticals Major industry is in the same range as TVRD (61) in the null industry. This means that NIKI’s stock grew similarly to TVRD’s over the last 12 months.
NIKI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as TVRD (100) in the null industry. This means that NIKI’s stock grew similarly to TVRD’s over the last 12 months.
NIKI's SMR Rating (92) in the Pharmaceuticals Major industry is in the same range as TVRD (99) in the null industry. This means that NIKI’s stock grew similarly to TVRD’s over the last 12 months.
TVRD's Price Growth Rating (61) in the null industry is somewhat better than the same rating for NIKI (97) in the Pharmaceuticals Major industry. This means that TVRD’s stock grew somewhat faster than NIKI’s over the last 12 months.
NIKI's P/E Growth Rating (6) in the Pharmaceuticals Major industry is in the same range as TVRD (7) in the null industry. This means that NIKI’s stock grew similarly to TVRD’s over the last 12 months.
| NIKI | TVRD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Stochastic ODDS (%) | N/A | 2 days ago 90% |
| Momentum ODDS (%) | N/A | 2 days ago 80% |
| MACD ODDS (%) | 2 days ago 82% | 2 days ago 71% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 76% |
| Advances ODDS (%) | 3 days ago 81% | 3 days ago 81% |
| Declines ODDS (%) | 7 days ago 90% | 13 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 87% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
NIKI’s FA Score shows that 1 FA rating(s) are green while TVRD’s FA Score has 1 green FA rating(s).
- NIKI’s FA Score: 1 green, 4 red.
- TVRD’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
NIKI’s TA Score shows that 4 TA indicator(s) are bullish while TVRD’s TA Score has 4 bullish TA indicator(s).
- NIKI’s TA Score: 4 bullish, 2 bearish.
- TVRD’s TA Score: 4 bullish, 5 bearish.
Price Growth
NIKI (@Biotechnology) experienced а -9.04% price change this week, while TVRD (@Biotechnology) price change was +68.88% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was -2.72%, and the average quarterly price growth was -13.41%.
Reported Earning Dates
TVRD is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Biotechnology (+4.90% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
NIKI and
Correlation & Price change
A.I.dvisor indicates that over the last year, NIKI has been loosely correlated with HLSQ. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if NIKI jumps, then HLSQ could also see price increases.
| Ticker / NAME | Correlation To NIKI | 1D Price Change % | ||
|---|---|---|---|---|
| NIKI | 100% | -8.00% | ||
| HLSQ - NIKI | 60% Loosely correlated | -37.43% | ||
| CANF - NIKI | 48% Loosely correlated | -1.19% | ||
| APVO - NIKI | 46% Loosely correlated | -4.42% | ||
| ICU - NIKI | 45% Loosely correlated | -3.06% | ||
| MLEC - NIKI | 45% Loosely correlated | N/A | ||
More | ||||
TVRD and
Correlation & Price change
A.I.dvisor indicates that over the last year, TVRD has been loosely correlated with TOVX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TVRD jumps, then TOVX could also see price increases.
| Ticker / NAME | Correlation To TVRD | 1D Price Change % | ||
|---|---|---|---|---|
| TVRD | 100% | N/A | ||
| TOVX - TVRD | 41% Loosely correlated | -7.00% | ||
| JSPR - TVRD | 27% Poorly correlated | -9.90% | ||
| NIKI - TVRD | 27% Poorly correlated | -8.00% | ||
| NRXP - TVRD | 27% Poorly correlated | -0.84% | ||
| VSTM - TVRD | 27% Poorly correlated | +0.34% | ||
More | ||||